Detalhe da pesquisa
1.
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence.
Cancers (Basel)
; 15(3)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765565
2.
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases.
Int J Environ Res Public Health
; 18(11)2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070561
3.
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis.
Cancers (Basel)
; 13(5)2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802269
4.
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial.
Biomedicines
; 8(5)2020 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365877
5.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes.
Minerva Chir
; 74(3): 195-202, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29589675